COVID-19 Monoclonal Antibody Treatment Information for Long Term Care & Assisted Living Facilities

Having trouble viewing this email? View it as a Web page. COVID-19 Monoclonal Antibody Treatment Information for Long Term Care & Assisted Living Facilities January 3, 2022 The Maine Department of Health and Human Services has assembled an information toolkit for Long Term Care, Assisted Living Facilities, and Group Homes regarding the Monoclonal Antibody (mAb) Treatment available to residents.  For questions or other related issues, providers may also contact Dr Lisa Letourneau at ME DHHS: lisa.letourneau@maine.gov. For more information on mAb therapies, visit https://combatcovid.hhs.gov Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit subscriberhelp.govdelivery.com. This service is provided to you at no charge by Maine Department of Health & Human Services. This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: Maine Department of Health & Human Services · 109 Capitol St · Augusta, ME 04333